PLAINSBORO, N.J., Oct. 2, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it closed the acquisition of the United States rights to Tornier’s Salto Talaris® and Salto Talaris® XT ankle replacement products and Tornier’s Futura™ silastic toe replacement

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone